Adding Cyclerion Thera (CYCN) $3.75, to Biotech Stock Review Watch List.
From the Tiki Hut Fund
Cyclerion Therapeutics Inc (CYCN) | And We Have Deal, Up 30%.
LIVE...
More Great News From Citius Pharma (CTXR).
UPDATED CHART 6-15-21
Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
Adding GBT Technologies (GTCH) to the Watch List.
Massive Potential From California Based Technology Think Tank.
Yes, risky - as in...
Adding Auris Medical (EARS) $3.50 to Biotech Watch List.
Auris Medical soared 590% in one Week on Covid Related News on December 1st, 2020.
LIFT OFF...
Hapbee (HAPBF) Selects Accomplished Technology and Consumer Products Entrepreneur & Executive as CEO.
Transformational Entrepreneur Yona Shtern to Lead Hapbee as it Advances Commercialization Phase of Business Development
VANCOUVER, BC, June 2, 2021 /PRNewswire/...
GBT (GTCH) Is Researching To Develop An AI Empowered, Wireless Patient Health Monitoring System
The researched technology, is aiming to create a Radio-Based patient health monitoring system for homes or facilities
SAN...
Stocks On The Move!
Citius (CTXR) up 19%, Draganfly (DFLYF) up 31%, urban-gro (UGRO) up 37%, Provention (PVRB) flip-flopping, Hapbee Technologies (HAPBF) up 26% and the...
Tiki Hut Fund. The Past Year’s Biggest Losers!
The Past Year's Biggest Losers!
Here's an interesting look at the biggest losers...
Draganfly (DFLYF)Announces Record Revenues & Shareholder Call.
LIVE QUOTE
Vancouver, BC, May 27, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB:...
Provention Bio (PRVB) Updates.
LATEST UPDATE July 13th, 2022, below.
(2021) We're getting way too many calls on...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
